Target intelligence / Profile preview

Cytochrome b-c1 complex subunit 8 (UQCRQ)

Target
UQCRQ
Molecular classification
Mitochondrial respiratory chain complex protein, Enzyme complex subunit (Complex III of electron transport chain)
01

Overview

Cytochrome b-c1 complex subunit 8 (UQCRQ) is a small, low-molecular-mass protein that forms part of the ubiquinol-cytochrome c reductase complex (Complex III) in the mitochondrial respiratory chain[1][3][7]. UQCRQ acts as a ubiquinone-binding protein and is integral for the electron transfer from ubiquinol to cytochrome c, a process that drives proton translocation across the mitochondrial inner membrane and is essential for oxidative phosphorylation and ATP generation. Mutations in UQCRQ are linked to mitochondrial complex III deficiency, manifesting in various metabolic and neurometabolic diseases[1][3]. Although there are no drugs targeting UQCRQ specifically, inhibitors of Complex III can impact this protein’s function and mitochondrial bioenergetics[7].

Other names
Cytochrome b-c1 complex subunit 8UQCRQQCR8QP-CQCR7Complex III subunit 8Complex III subunit VIIUbiquinol-cytochrome c reductase complex 9.5 kDa proteinUbiquinol-cytochrome c reductase complex ubiquinone-binding protein QP-C9.5 kDa proteinlow molecular mass ubiquinone-binding protein (9.5kD)
02

Mechanism of action

Inhibition of Complex III disrupts electron flow from ubiquinol to cytochrome c, collapsing the mitochondrial membrane potential and reducing ATP synthesis

03

Biological functions

Electron transport (mitochondrial electron transport chain)Oxidative phosphorylationCellular energy production (ATP synthesis)
04

Disease associations

Mitochondrial complex III deficiency (nuclear type 4)Isolated complex III deficiencyPotential roles in neurometabolic and metabolic disorders
05

Safety considerations

Global inhibition of Complex III (including UQCRQ) can lead to severe mitochondrial dysfunction and is associated with toxicity in non-target tissues due to impaired ATP production
06

Interacting drugs

None directly documented as specific for UQCRQ; however, the entire Complex III is globally targeted by antimycotic drugs such as antimycin A and experimental agents
07

Biomarkers

UQCRQ mutation or protein level may serve as a biomarker for mitochondrial Complex III deficiency

Beyond the preview

Go deeper on Cytochrome b-c1 complex subunit 8 (UQCRQ).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytochrome b-c1 complex subunit 8 (UQCRQ).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call